Colon CancerInfo Center
New Colon Cleanse Approved
Cleaning out the colon is one of the things people hate about having a colonoscopy. A new preparation formula is now available for this unpleasant task.
Turning Cancer into a Manageable Disease
Some cancers can be eliminated, while some can be put into remission. Others can become like chronic diseases that are managed with medication. One researcher sees the latter group growing in the near future.
Calming the Cancer of Inflammation
Inflammatory bowel diseases ( IBD ) such as ulcerative colitis and Crohn's disease are major risk factors for colorectal cancer. Why? Because these diseases cause constant inflammation - something cancer thrives on.
Who Should Pay for This Cancer Screening?
Not too many people even like to think about what's involved in a colonoscopy. This may be why 40-50 percent of folks just skip the colorectal cancer screening.
Triple Therapy for Liver Troubles
Finding that your cancer has metastasized can make it hard to stay hopeful, but hard-hitting new treatment for colorectal cancer tumors that have turned up in the liver has shown good results.
Urine Test for Colon Cancer?
Metabolomics is the science of examining the waste products of cells. In other words, it looks at the end products of cell metabolism.
Colorectal Cancer Bolder in Gen Y
It's certainly unusual, but colorectal cancer does appear in people younger than age 50. You would think that the disease might be gentler in this age group, and you would be wrong. There's a positive twist to this story, though.
Single Punches Don't Knock Out Advanced Cancers
Once cancer starts to move, it's hard to take out. A single punch isn't going to knock it out. All is not lost, though. Combination therapies may deliver the blow that starts the count down.
Childhood Cancer Warriors at Higher Risk of GI Cancers
Gastrointestinal cancers show up anywhere along the digestive tract. And while risk factors for each organ vary, a separate group of people appear to be at greater risk.
Avastin Prolongs Life of Colorectal Cancer Patients
Treating colorectal cancer that has spread to other sites involves a combination of chemotherapies. One regimen that's been in use has been proven to extend life and is likely to become the standard of care. A phase III trial has found that continued use of Avastin ( bevacizumab ), along with different first- and second-line chemotherapies, prevents the disease from progressing by 1.6 months longer than traditional therapy. This research also indicates that people using Avastin lived with advanced colorectal cancer another 1.4 months. Ask your doctor the exact benefits of all th...